Washington | US pharmaceutical giant Pfizer plans to seek emergency authorization for its COVID-19 vaccine from US authorities in the third week of November, its CEO announced on Friday.
• Read also: All developments in the COVID-19 pandemic
• Read also: Remdesivir has “little or no effect” on mortality
• Read also: Treatments against COVID, some progress
“Let me be clear, assuming the data is positive, Pfizer will apply for emergency use authorization in the United States shortly after the safety milestone has been passed, during the third week of November, ”said Albert Bourla in an open letter posted on social networks.